首页> 外文期刊>Experimental and therapeutic medicine >A comparison of adeB gene expression levels under conditions of induced resistance by different drugs in vitro in Acinetobacter baumannii
【24h】

A comparison of adeB gene expression levels under conditions of induced resistance by different drugs in vitro in Acinetobacter baumannii

机译:在肺杆菌中不同药物诱导性抗性抗性抗性条件下的ADEB基因表达水平的比较

获取原文
获取原文并翻译 | 示例

摘要

The present study was designed to analyze the difference of the adeB gene expression levels under conditions of induced resistance and to verify the significance of the AdeABC efflux pump in the in vitro induction of Acinetobacter baumannii (A. baumannii). Strains were isolated from blood or drainage samples in the First Hospital of China Medical University. The minimum inhibitory concentration (MIC) was determined by a broth microdilution method. In addition, an in vitro induction of drug-resistance tests was confirmed with the three drugs. The expression level of the adeB was determined by quantitative polymerase chain reaction (qPCR), and there were 19, 17 and 25 strains isolated from this test that were susceptible to amikacin, netilmicin and imipenem, respectively. Furthermore, 11, 15 and 8 stably resistant strains generated against amikacin, netilmicin and imipenem, respectively, by in vitro induction. The MIC values of all the imipenem-sensitive and imipenem-resistant strains decreased by no more than 2-fold under carbonyl cyanide 3-chlorophenylhydrazone (CCCP)-containing conditions. The MIC values of 10 amikacin-resistant and 14 netilmicin-resistant strains decreased 4-fold or more under CCCP-containing conditions. Furthermore, qPCR revealed that none of the imipenem-sensitive or the imipenem-resistant strains expressed the adeB gene, but there were 10 amikacin-resistant and 5 netilmicin-resistant strains that expressed the adeB gene. In conclusion, the present study confirmed that in vitro induction of drug-resistance tests in sensitive A. baumannii strains could produce drug-resistance following long-term exposure to low doses of antibacterial drugs. In addition, amikacin and netilmicin are more prone to producing drug-resistance compared to imipenem in vitro. The results of the efflux phenotype indicate the possible application of CCCP in the inhibition of the efflux system in some drugs. The inconsistency between efflux phenotype and qPCR of adeB indicates that other mechanisms may also be included in the induction of drug-resistance that work with the active mechanism in order to increase drug resistance to common clinically-used antimicrobial drugs.
机译:本研究旨在在诱导抗性的条件下分析ADEB基因表达水平的差异,并验证ADEABC Efflux泵在体外诱导的患者Baumannii(A.Baumannii)的体外诱导中的意义。从中国医科大学第一医院的血液或排水样品中分离出菌株。通过肉汤微量稀释方法测定最小抑制浓度(MIC)。此外,用三种药物证实了药物抗性试验的体外诱导。通过定量聚合酶链反应(QPCR)测定ADEB的表达水平,分别从该试验中分离有19,17和25个菌株,分别易于Amikacin,Netilmicin和ImipeNem。此外,通过体外诱导分别在氨基辛,Netilmicin和Imipenem产生的11,15和8稳定的抗性菌株。所有亚氨植物敏感和亚氨尼抗性菌株的MIC值在羰基氰化物3-氯苯基腙(CCCP)条件下降低不超过2倍。在含CCCP的条件下,10个Amikacin抗性和14个Netilmicin抗性菌株的MIC值降低了4倍或更高。此外,QPCR揭示了亚氨敏感或亚胺尼抗性菌株没有表达ADEB基因,但有10个抗AdeB基因的Amikacin抗性和5个Netilmicin抗性菌株。总之,本研究证实,在敏感A中的抗药性试验中的体外诱导。Baumannii菌株可以在长期暴露于低剂量的抗菌药物后产生耐药性。此外,与Imipenem在体外相比,Amikacin和Netilmicin更容易发生耐药性。流出表型的结果表明CCCP在一些药物中抑制中源系统的应用。排出表型和ADEB QPCR之间的不一定表明,其他机制也可以包括在抗体机制的抗药性中,以提高对常见的临床用抗微生物药物的耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号